Identification and characterization of a novel retroviral-like aspartic protease specifically expressed in human epidermis

Journal of Investigative Dermatology

Volumn 125, Issue 2, 2005, Pages 278-287

  Bernard, D ^a,c   Mehul B ^b   Thomas Collignon, A ^a   Delattre, C ^a   Donovan, M ^a   Schmidt, R ^a  

^a L ORÉAL RECHERCHE   (France)

^b Galderma R and D   (France)

^c Centre Charles Zviak   (France)

Author keywords

Epidermis; HIV protease inhibitors; Proteases; Proteomics; Retropepsin; Skin

Indexed keywords

ASPARTIC PROTEINASE; HYBRID PROTEIN; INDINAVIR; PROTEINASE INHIBITOR; RECOMBINANT ENZYME; RECOMBINANT SKIN ASPARTIC PROTEASE; UNCLASSIFIED DRUG; MESSENGER RNA; SKIN ASPARTIC PROTEASE, HUMAN;

ARTICLE; CLONING; CONTROLLED STUDY; ENZYME ANALYSIS; EPIDERMIS; ESCHERICHIA COLI; GEL ELECTROPHORESIS; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING; AMINO ACID SEQUENCE; CELL CULTURE; CHEMISTRY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; RETROVIRUS;

AMINO ACID SEQUENCE; ASPARTIC ENDOPEPTIDASES; BASE SEQUENCE; CELLS, CULTURED; ENZYME ACTIVATION; EPIDERMIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RETROVIRIDAE; RNA, MESSENGER;

EID: 24344470208     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23816.x     Document Type: Article

References (56)

1. Benit L, Lallemand JB, Casella JF, Philippe H, Heidmann T: ERV-L elements: A family of endogenous retrovirus-like elements active throughout the evolution of mammals. J Virol 73:3301-3308, 1999
2. Bernard D, Mehul B, Thomas-Collignon A, Simonetti L, Remy V, Bernard MA, Schmidt R: Analysis of proteins with caseinolytic activity in a human stratum corneum extract revealed a yet unidentified cysteine protease and identified the so-called "stratum corneum thiol protease" as cathepsin 12. J Invest Dermatol 120:592-600, 2003
3. Bouscarat F, Bouchard C, Bouhour D: Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir. N Engl J Med 338:1776-1777, 1998
4. Brattsand M, Egelrud T: Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biol Chem 274:30033-30040, 1999
5. Calista D, Boschini A: Cutaneous side effects induced by indinavir. Eur J Dermatol 10:292-296, 2000
6. Carr A, Samaras K, Chisholm DJ, Cooper DA: Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351:1881-1883, 1998
7. Caubet C, Jonca N, Brattsand M, et al: Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 122:1235-1244, 2004
8. Chang WJ, Horiuchi S, Takahashi K, Yamasaki M, Yamada Y: The structure and function of acid proteases. VI. Effects of acid protease-specific inhibitors on the acid proteases from Aspergillus niger var. macrosporus. J Biochem (Tokyo) 80:975-981, 1976
9. Dunn BM, Goodenow MM, Gustchina A, Wlodawer A: Retroviral proteases. Genome Biol 3:reviews3006.1-3006.7, 2002
10. Egelrud T, Lundstrom A: A chymotrypsin-like proteinase that may be involved in desquamation in plantar stratum corneum. Arch Dermatol Res 283: 108-112, 1991
11. Garcia-Silva J, Almagro M, Juega J, Pena C, Lopez-Calvo S, del Pozo J, Fonseca E: Protease inhibitor-related paronychia, ingrown toenails, desquamative cheilitis and cutaneous xerosis. Aids 14:1289-1291, 2000
12. Garcia-Silva J, Almagro M, Pena-Penabad C, Fonseca E: Indinavir-induced retinoid-like effects: Incidence, clinical features and management. Drug Saf 25:993-1003, 2002
13. Ghibelli L, Mengoni F, Lichtner M, et al: Anti-apoptotic effect of HIV protease inhibitors via direct inhibition of calpain. Biochem Pharmacol 66:1505-1512, 2003
14. Hansson L, Stromqvist M, Backman A, Wallbrandt P, Carlstein A, Egelrud T: Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J Biol Chem 269:19420-19426, 1994
15. Harry TC, Matthews M, Salvary I: Indinavir use: Associated reversible hair loss and mood disturbance. Int J STD AIDS 11:474-476, 2000
16. Horikoshi T, Arany I, Rajaraman S, et al: Isoforms of cathepsin D and human epidermal differentiation. Biochimie 80:605-612, 1998
17. Johansen T, Holm T, Bjorklid E: Members of the RTVL-H family of human endogenous retrovirus-like elements are expressed in placenta. Gene 79:259-267, 1989
18. Kay J, Dunn BM: Viral proteinases: Weakness in strength. Biochim Biophys Acta 1048:1-18, 1990
19. Kelley LA, MacCallum RM, Sternberg MJ: Enhanced genome annotation using structural profiles in the program 3D-PSSM. J Mol Biol 299:499-520, 2000
20. Kim HC, Nemes Z, Idler WW, Hyde CC, Steinert PM, Ahvazi B: Crystallization and preliminary X-ray analysis of human transglutaminase 3 from zymogen to active form. J Struct Biol 135:73-77, 2001
21. Kim SY, Bae CD: Calpain inhibitors reduce the cornified cell envelope formation by inhibiting proteolytic processing of transglutaminase 1. Exp Mol Med 30:257-262, 1998
22. Kohl NE, Emini EA, Schleif WA, et al: Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci USA 85: 4686-4690, 1988
23. Komatsu N, Takata M, Otsuki N, Toyama T, Ohka R, Takehara K, Saijoh K: Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J Invest Dermatol 121:542-549, 2003
24. Kuwae K, Matsumoto-Miyai K, Yoshida S, Sadayama T, Yoshikawa K, Hosokawa K, Shiosaka S: Epidermal expression of serine protease, neuropsin (KLK8) in normal and pathological skin samples. Mol Pathol 55:235-241, 2002
25. Lenhard JM, Weiel JE, Paulik MA, Furfine ES: Stimulation of vitamin A(1) acid signaling by the HIV protease inhibitor indinavir. Biochem Pharmacol 59:1063-1068, 2000
26. Lin XL, Lin YZ, Koelsch G, Gustchina A, Wlodawer A, Tang J: Enzymic activities of two-chain pepsinogen, two-chain pepsin, and the amino-terminal lobe of pepsinogen. J Biol Chem 267:17257-17263, 1992
27. Lippens S, Kockx M, Knaapen M, et al: Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ 7:1218-1224, 2000
28. List K, Haudenschild CC, Szabo R, et al: Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21:3765-3779, 2002
29. List K, Szabo R, Wertz PW, Segre J, Haudenschild CC, Kim SY, Bugge TH: Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J Cell Biol 163:901-910, 2003
30. Lower R, Lower J, Kurth R: The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 93:5177-5184, 1996
31. Meek TD, Dayton BD, Metcalf BW, et al: Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease. Proc Natl Acad Sci USA 86:1841-1845, 1989
32. Mehul B, Bernard D, Simonetti L, Bernard MA, Schmidt R: Identification and cloning of a new calmodulin-like protein from human epidermis. J Biol Chem 275:12841-12847, 2000
33. Mikolajczyk J, Scott FL, Krajewski S, Sutherlin DP, Salvesen GS: Activation and substrate specificity of caspase-14. Biochemistry 43:10560-10569, 2004
34. Patience C, Wilkinson DA, Weiss RA: Our retroviral heritage. Trends Genet 13:116-120, 1997
35. Pearl LH, Taylor WR: A structural model for the retroviral proteases. Nature 329:351-354, 1987
36. Pearton DJ, Nirunsuksiri W, Rehemtulla A, Lewis SP, Presland RB, Dale BA: Proprotein convertase expression and localization in epidermis: Evidence for multiple roles and substrates. Exp Dermatol 10:193-203, 2001
37. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C: Human and mouse proteases: A comparative genomic approach. Nat Rev Genet 4:544-558, 2003
38. Rendl M, Ban J, Mrass P, et al: Caspase-14 expression by epidermal keratinocytes is regulated by retinoids in a differentiation-associated manner. J Invest Dermatol 119:1150-1155, 2002
39. 2+ in the second stage. J Biol Chem 268:25139-25145, 1993
40. Resing KA, Thulin C, Whiting K, al-Alawi N, Mostad S: Characterization of profilaggrin endoproteinase 1. A regulated cytoplasmic endoproteinase of epidermis. J Biol Chem 270:28193-28198, 1995
41. Sadowski T, Dietrich S, Muller M, et al: Matrix metalloproteinase-19 expression in normal and diseased skin: Dysregulation by epidermal proliferation. J Invest Dermatol 121:989-996, 2003
42. Scott G, Deng A, Rodriguez-Burford C, et al: Protease-activated receptor 2, a receptor involved in melanosome transfer, is upregulated in human skin by ultraviolet irradiation. J Invest Dermatol 117:1412-1420, 2001
43. Serre G, Mils V, Haftek M, et al: Identification of late differentiation antigens of human cornified epithelia, expressed in re-organized desmosomes and bound to cross-linked envelope. J Invest Dermatol 97:1061-1072, 1991
44. Shoeman RL, Honer B, Stoller TJ, Kesselmeier C, Miedel MC, Traub P, Graves MC: Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein. Proc Natl Acad Sci USA 87:6336-6340, 1990
45. Simon M, Jonca N, Guerrin M, et al: Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem 276:20292-20299, 2001
46. Steinhoff M, Corvera CU, Thoma MS, et al: Proteinase-activated receptor-2 in human skin: Tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8:282-294, 1999
47. Tang J, James MN, Hsu IN, Jenkins JA, Blundell TL: Structural evidence for gene duplication in the evolution of the acid proteases. Nature 271:618-621, 1978
48. Tobin DJ, Foitzik K, Reinheckel T, Mecklenburg L, Botchkarev VA, Peters C, Paus R: The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling. Am J Pathol 160:1807-1821, 2002
49. Toma E, Devost D, Chow Lan N, Bhat PV: HIV-protease inhibitors alter retinoic acid synthesis. Aids 15:1979-1984, 2001
50. Tomasselli AG, Howe WJ, Hui JO, et al: Calcium-free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2. Proteins 10: 1-9, 1991
51. Tomasselli AG, Hui JO, Adams L, et al: Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus. J Biol Chem 266:14548-14553, 1991
52. Tomaszek TA, Moore ML, Strickler JE, et al: Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease. Biochemistry 31:10153-10168, 1992
53. Toomes C, James J, Wood AJ, et al: Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 23:421-424, 1999
54. Van de Craen M, Van Loo G, Pype S, et al: Identification of a new caspase homologue: Caspase-14. Cell Death Differ 5:838-846, 1998
55. Ward HA, Russo GG, Shrum J: Cutaneous manifestations of antiretroviral therapy. J Am Acad Dermatol 46:284-293, 2002
56. Wlodawer A, Gustchina A: Structural and biochemical studies of retroviral proteases. Biochim Biophys Acta 1477:16-34, 2000